JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.04 USD | -0.14% |
|
-2.04% | -6.68% |
| Dec. 12 | J&J: FDA extends indication for Impella heart pumps | CF |
| Dec. 11 | Citigroup Adjusts Price Target on Johnson & Johnson to $175 From $185, Keeps Buy Rating | MT |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Innovative Medicine | 42.2B | 45.57B | 52.08B | 52.56B | 54.76B | |||||
Total Assets | 56.29B | 66.16B | 64.38B | 58.44B | 58.32B | |||||
CAPEX | -950M | -863M | -1.2B | -1.37B | -1.65B | |||||
EBT | 8.82B | 15.46B | 18.18B | 15.9B | 18.25B | |||||
D&A | 3.91B | 4.01B | 4.03B | 3.69B | 3.85B | |||||
Therapeutic Devices | ||||||||||
Medtech | 25.96B | 22.96B | 27.06B | 27.43B | 30.4B | |||||
Total Assets | 49.46B | 49.58B | 53.37B | 70.96B | 74.71B | |||||
CAPEX | -1.91B | -1.98B | -1.93B | -2.12B | -2.37B | |||||
EBT | 7.29B | 3.04B | 4.37B | 4.61B | 4.67B | |||||
D&A | 2.01B | 2.14B | 2.29B | 2.3B | 2.94B | |||||
Total Assets | 25.36B | 31.8B | 39.19B | 33.92B | 34.52B | |||||
CAPEX | -308M | -256M | -190M | -192M | -356M | |||||
D&A | 320M | 300M | 316M | 323M | 313M | |||||
EBT | -835M | -945M | -1.07B | -624M | -7.85B | |||||
EBT | - | - | - | -1.09B | - | |||||
Baby Care Products | ||||||||||
Consumer Health | 13.9B | 14.05B | 14.64B | 14.95B | - | |||||
Total Assets | 26.62B | 27.36B | 25.08B | 24.07B | - | |||||
CAPEX | -328M | -248M | -331M | -323M | - | |||||
EBT | 2.06B | -1.06B | 1.29B | 2.93B | - | |||||
D&A | 765M | 785M | 759M | 658M | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 42.1B | 43.13B | 47.16B | 48.58B | 46.44B | |||||
Total Assets | 41.53B | 49.95B | 48.59B | 66.28B | 54.83B | |||||
Europe | 18.47B | 18.98B | 23.59B | 23.45B | 20.41B | |||||
Total Assets | 48.02B | 49.36B | 43.26B | 38.77B | 31.62B | |||||
Asia-Pacific, Africa | 15.56B | 15.14B | 17.28B | 16.79B | 13.76B | |||||
Total Assets | 5.49B | 5.48B | 5.04B | 4.43B | 1.5B | |||||
Western Hemisphere, Excluding U.S. | 5.94B | 5.34B | 5.75B | 6.12B | 4.55B | |||||
Total Assets | 2.86B | 2.73B | 2.71B | 2.74B | 1.49B | |||||
Total Assets | 1.05B | 1.03B | 1.01B | 1.13B | 1.19B | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 58.79B | 66.33B | 81.42B | 74.02B | 76.93B |
- Stock Market
- Equities
- JNJ Stock
- Financials Johnson & Johnson
- Business Segments